Covered recipient · General Payments record
JORGE ARMANDO URIBE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,369.05
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.37 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $235.13 | 16 |
| Acerta Pharma LLC | $70.73 | 4 |
| Amgen Inc. | $49.28 | 2 |
| Sandoz Inc. | $32.67 | 1 |
| GENZYME CORPORATION | $18.35 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261562 | CMS |
| ABBVIE INC. | $10.44 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261564 | CMS |
| ABBVIE INC. | $31.26 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261566 | CMS |
| ABBVIE INC. | $9.82 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261568 | CMS |
| ABBVIE INC. | $12.38 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261570 | CMS |
| ABBVIE INC. | $12.30 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261572 | CMS |
| ABBVIE INC. | $9.98 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261574 | CMS |
| ABBVIE INC. | $21.07 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261576 | CMS |
| ABBVIE INC. | $10.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261578 | CMS |
| ABBVIE INC. | $8.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261580 | CMS |
| ABBVIE INC. | $10.35 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261582 | CMS |
| ABBVIE INC. | $29.19 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261584 | CMS |
| ABBVIE INC. | $9.58 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261586 | CMS |
| ABBVIE INC. | $10.24 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261588 | CMS |
| ABBVIE INC. | $12.12 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261590 | CMS |
| ABBVIE INC. | $17.74 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106261592 | CMS |
| Amgen Inc. | $27.16 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730341 | CMS |
| Amgen Inc. | $22.12 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730343 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.35 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104342824 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.83 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105899490 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105638014 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105557428 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.21 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118108555 | CMS |
| GENZYME CORPORATION | $18.35 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139908533 | CMS |
| Sandoz Inc. | $32.67 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089372333 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.